Misoprostol/Naproxen

米索前列醇/萘普生

Report date: 2022/03/14 18:05:39

Base Information

Drug NameMisoprostol/Naproxen
Drug Alias Namemisoprostol+NSAID萘普生/米索前列醇Naproxen/Misoprostol米索前列醇+萘普生Naproxen+Misoprostol +[8
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProstanoid EP2 receptor agonists
TargetsProstanoid EP2 receptorCyclooxygenases
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NaproxenMisoprostol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsN/A

Other Information

ATC CodeM01AE56
Related LinksN/A